GB0225042D0 - Pharmaceutical composition - Google Patents
Pharmaceutical compositionInfo
- Publication number
- GB0225042D0 GB0225042D0 GB0225042A GB0225042A GB0225042D0 GB 0225042 D0 GB0225042 D0 GB 0225042D0 GB 0225042 A GB0225042 A GB 0225042A GB 0225042 A GB0225042 A GB 0225042A GB 0225042 D0 GB0225042 D0 GB 0225042D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (38)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/508,336 US7666876B2 (en) | 2002-03-19 | 2002-03-19 | Buprenorphine formulations for intranasal delivery |
GB0225042A GB0225042D0 (en) | 2002-10-28 | 2002-10-28 | Pharmaceutical composition |
PCT/GB2003/001183 WO2003080021A2 (en) | 2002-03-19 | 2003-03-19 | Formulation comprising buprenorphine |
KR1020117000035A KR20110005919A (en) | 2002-03-19 | 2003-03-19 | Formulation comprising buprenorphine |
PT03715087T PT1513493E (en) | 2002-03-19 | 2003-03-19 | Analgesics |
ES03712380T ES2315485T3 (en) | 2002-03-19 | 2003-03-19 | FORMULATION UNDERSTANDING BUPRENORFINA. |
ES03715087T ES2325364T3 (en) | 2002-03-19 | 2003-03-19 | ANALGESICS. |
AT03715087T ATE422902T1 (en) | 2002-03-19 | 2003-03-19 | ANALGESICS |
PCT/GB2003/001184 WO2003080022A2 (en) | 2002-03-19 | 2003-03-19 | Analgesics for nasal administration |
NZ535973A NZ535973A (en) | 2002-03-19 | 2003-03-19 | Opioid analgesics and non-steroidal anti-inflammatory drugs (NSAIDs) for nasal administration |
DE60326231T DE60326231D1 (en) | 2002-03-19 | 2003-03-19 | ANALGESIC |
KR1020047014665A KR101030403B1 (en) | 2002-03-19 | 2003-03-19 | Formulation comprising buprenorphine |
CA002479718A CA2479718A1 (en) | 2002-03-19 | 2003-03-19 | Analgesics for nasal administration |
JP2003577851A JP4728580B2 (en) | 2002-03-19 | 2003-03-19 | Formulation |
EP03715087A EP1513493B8 (en) | 2002-03-19 | 2003-03-19 | Analgesics |
BRPI0308527-9A BRPI0308527B1 (en) | 2002-03-19 | 2003-03-19 | Aqueous solution suitable for intranasal administration, process for preparing an aqueous solution, nasal delivery device, and use of an aqueous solution |
AT03712380T ATE410187T1 (en) | 2002-03-19 | 2003-03-19 | PREPARATION CONTAINING BUPRENORPHINE |
DE60323958T DE60323958D1 (en) | 2002-03-19 | 2003-03-19 | BUPRENORPHINE CONTAINING PREPARATION |
IL16412903A IL164129A0 (en) | 2002-03-19 | 2003-03-19 | Formulation for intranalsal administration |
DK03715087T DK1513493T3 (en) | 2002-03-19 | 2003-03-19 | analgesics |
US10/508,315 US20050142072A1 (en) | 2002-03-19 | 2003-03-19 | Analgesics for nasal administration |
AU2003216842A AU2003216842B2 (en) | 2002-03-19 | 2003-03-19 | Formulation comprising buprenorphine |
MXPA04009055A MXPA04009055A (en) | 2002-03-19 | 2003-03-19 | Formulation comprising buprenorphine. |
GB0318346A GB2397016B (en) | 2002-03-19 | 2003-03-19 | Intranasal analgesic composition containing buprenorphine |
NZ535972A NZ535972A (en) | 2002-03-19 | 2003-03-19 | Formulation comprising buprenorphine |
CA2479711A CA2479711C (en) | 2002-03-19 | 2003-03-19 | Formulation |
EP03712380A EP1499360B1 (en) | 2002-03-19 | 2003-03-19 | Formulation comprising buprenorphine |
JP2003577852A JP2005527535A (en) | 2002-03-19 | 2003-03-19 | Analgesics |
CN038063646A CN1642577B (en) | 2002-03-19 | 2003-03-19 | Preparation comprising buprenorphine |
DK03712380T DK1499360T3 (en) | 2002-03-19 | 2003-03-19 | Formulation comprising buprenorphine |
SI200331468T SI1499360T1 (en) | 2002-03-19 | 2003-03-19 | Formulation comprising buprenorphine |
AU2003219282A AU2003219282A1 (en) | 2002-03-19 | 2003-03-19 | Analgesics for nasal administration |
EP07020868A EP1878446A3 (en) | 2002-03-19 | 2003-03-19 | Formulation comprising buprenorphine |
IL164129A IL164129A (en) | 2002-03-19 | 2004-09-19 | Intranasal analgesic composition comprising buprenorphine |
US11/798,384 US20070231269A1 (en) | 2002-03-19 | 2007-05-14 | Analgesics |
US12/588,528 US20100041624A1 (en) | 2002-03-19 | 2009-10-19 | Buprenorphine formulations for intranasal delivery |
JP2010071698A JP2010174029A (en) | 2002-03-19 | 2010-03-26 | Analgesic |
US12/929,279 US20110105551A1 (en) | 2002-03-19 | 2011-01-12 | Analgesics for nasal administration |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0225042A GB0225042D0 (en) | 2002-10-28 | 2002-10-28 | Pharmaceutical composition |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0225042D0 true GB0225042D0 (en) | 2002-12-04 |
Family
ID=9946713
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0225042A Ceased GB0225042D0 (en) | 2002-03-19 | 2002-10-28 | Pharmaceutical composition |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB0225042D0 (en) |
-
2002
- 2002-10-28 GB GB0225042A patent/GB0225042D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2389530B (en) | Pharmaceutical compositions | |
AU2003291103A8 (en) | Pharmaceutical composition | |
IL164547A0 (en) | Pharmaceutical composition | |
GB2391473B (en) | Pharmaceutical compositions | |
IL165878A0 (en) | Pharmaceutical composition | |
GB0300427D0 (en) | Pharmaceutical composition | |
GB0307866D0 (en) | Pharmaceutical composition | |
EP1699458A4 (en) | Pharmaceutical composition | |
GB0329232D0 (en) | Pharmaceutical composition | |
GB0317663D0 (en) | Pharmaceutical composition | |
GB0213481D0 (en) | Pharmaceutical compositions | |
GB0300885D0 (en) | Pharmaceutical composition | |
HK1081451A1 (en) | Medicinal composition | |
HK1065477A1 (en) | Pharmaceutical composition | |
GB0306933D0 (en) | Pharmaceutical composition | |
HK1062274A1 (en) | Medicinal composition | |
GB0307869D0 (en) | Pharmaceutical composition | |
PL370907A1 (en) | Pharmaceutical compositions | |
GB0307864D0 (en) | Pharmaceutical composition | |
GB0307862D0 (en) | Pharmaceutical composition | |
GB0307867D0 (en) | Pharmaceutical composition | |
GB0217703D0 (en) | Pharmaceutical composition | |
EP1547593A4 (en) | Medicinal composition | |
GB0211448D0 (en) | Pharmaceutical composition | |
GB0213306D0 (en) | Pharmaceutical composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
COOA | Change in applicant's name or ownership of the application |
Owner name: CENTRE Free format text: FORMER APPLICANT(S): IONIX PHARMACEUTICALS LTD Owner name: IONIX PHARMACEUTICALS LTD Free format text: FORMER APPLICANT(S): IONIX PHARMACEUTICALS LTD Owner name: LIMITED Free format text: FORMER APPLICANT(S): IONIX PHARMACEUTICALS LTD Owner name: WEST PHARMACEUTICAL SERVICES DRUG DELIVERY & CLINI Free format text: FORMER APPLICANT(S): IONIX PHARMACEUTICALS LTD |
|
AT | Applications terminated before publication under section 16(1) |